Clinical trial
Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent…
NCT00080132 · Medical Research Laboratories International, Industry · Terminated
Key facts
| NCT number | NCT00080132 |
|---|---|
| Title | Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy |
| Official title | An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy |
| Lead sponsor | Medical Research Laboratories International, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | implitapide |
| Enrollment | 50 |
| Start date | Oct 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Mar 25, 2004 |
| Last update posted | Jun 24, 2005 |
| Countries | Netherlands, Norway, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: